Cleerly LABS vs Rapid PE Triage and Notification (PETN)
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is comprehensive, long-term management and detailed risk assessment of coronary artery disease. This tool is ideal for clinicians seeking to quantify plaque burden, characterize plaque types, and track disease progression over time to personalize treatment strategies and prevent future cardiac events.
View Cleerly LABS →Choose Rapid PE Triage and Notification (PETN) if…
Choose Rapid PE Triage and Notification (PETN) if your priority is the rapid identification and urgent notification of suspected central pulmonary embolisms in acute care settings. This solution is best suited for emergency departments and critical care units that need to accelerate diagnostic workflows and ensure timely intervention for life-threatening PE cases.
View Rapid PE Triage and Notification (PETN) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Rapid PE Triage and Notification (PETN) |
|---|---|---|
| Pricing | Varies | Contact for pricing |
| Deployment | Cloud, On-premise | On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification excels in usability for its acute care context, offering real-time notifications and mobile application access with in-app communication features that directly streamline urgent clinical workflows. While Cleerly LABS provides a rich diagnostic user experience with interactive web-based reports and 3D visualization, RapidAI's mobile-first approach for immediate action gives it an edge in its specific use case.
Clinical Value
Cleerly LABSCleerly LABS offers a more comprehensive and longitudinal clinical value by providing detailed, quantitative analysis of plaque characteristics, stenosis, and ischemia, enabling personalized heart disease management and tracking disease progression over time. Its extensive clinical validation demonstrates high diagnostic accuracy and prognostic utility for major adverse cardiovascular events, aiming to redefine preventative cardiology.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing per analysis and has achieved Category I CPT code reimbursement, significantly improving its value proposition and accessibility for patients and providers. Although its cost can still be out-of-pocket, the established reimbursement pathway offers a clearer financial model. Rapid PE's pricing remains undisclosed, making a direct value comparison difficult.
Enterprise Readiness
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification demonstrates superior enterprise readiness by offering flexible deployment options (on-premise, cloud, or hybrid) and a robust enterprise platform designed for unlimited scalability across health systems of any size. Its focus on seamless integration with existing hospital systems and a comprehensive platform for various disease states makes it highly adaptable for large-scale healthcare environments.
Innovation
Cleerly LABSCleerly LABS exhibits higher innovation by fundamentally shifting the paradigm of heart disease diagnosis and management from solely stenosis to comprehensive, quantitative characterization of atherosclerosis and its progression. Its mission to 'eliminate heart attacks' through personalized, preventative care based on detailed plaque analysis represents a more transformative approach to cardiovascular health.
Support & Docs
Rapid PE Triage and Notification (PETN)Rapid PE Triage and Notification explicitly details robust customer support, including 24/7/365 availability via email and phone, along with comprehensive resources like white papers, case studies, and professional education. This level of disclosed support is critical for enterprise-level healthcare solutions. Cleerly LABS does not provide specific details on its support and documentation in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Rapid PE Triage and Notification (PETN) |
|---|---|---|
| Tool Name | Cleerly LABS | Rapid PE Triage and Notification (PETN) |
| Company | Cleerly | RapidAI (formerly iSchemaView) |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms, streamlining workflow and accelerating patient care pathways. |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | CT Pulmonary Angiography (CTPA) |
| Key Clinical Focus | Atherosclerosis and stenosis detection, quantification, and characterization for heart disease management | Detection and notification of suspected central pulmonary embolisms (PE) |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Rapid PE Triage and Notification (PETN).
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Rapid PE Triage and Notification (PETN)
Backers
Who funded each tool's parent company.